BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 14989464)

  • 1. Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females.
    Conti G; Sergi B
    Acta Paediatr Suppl; 2003 Dec; 92(443):33-7; discussion 27. PubMed ID: 14989464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inner ear involvement in Anderson-Fabry disease: long-term follow-up during enzyme replacement therapy.
    Sergi B; Conti G; Paludetti G;
    Acta Otorhinolaryngol Ital; 2010 Apr; 30(2):87-93. PubMed ID: 20559478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Auditory and vestibular findings in Fabry disease: a study of 25 patients].
    Pichon M; Lidove O; Roudaire ML; Barry B; Herman P; Gobert D; Pasqualoni E; Compain C; Chauveheid MP; Papo T
    Rev Med Interne; 2012 Jul; 33(7):364-9. PubMed ID: 22365473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of vertigo and hearing loss in patients with Fabry disease.
    Köping M; Shehata-Dieler W; Schneider D; Cebulla M; Oder D; Müntze J; Nordbeck P; Wanner C; Hagen R; Schraven SP
    Orphanet J Rare Dis; 2018 Aug; 13(1):137. PubMed ID: 30111353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cochleo-vestibular lesions and prognosis in patients with profound sudden sensorineural hearing loss: a comparative analysis].
    Wu X; Liu M; Zhuang HW; Chen KT; Yang ZY; Xiong GX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):472-478. PubMed ID: 32842361
    [No Abstract]   [Full Text] [Related]  

  • 6. Inner ear dysfunction in myotonic dystrophy type 1.
    Balatsouras DG; Felekis D; Panas M; Xenellis J; Koutsis G; Kladi A; Korres SG
    Acta Neurol Scand; 2013 May; 127(5):337-43. PubMed ID: 23121018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.
    Ries M; Kim HJ; Zalewski CK; Mastroianni MA; Moore DF; Brady RO; Dambrosia JM; Schiffmann R; Brewer CC
    Brain; 2007 Jan; 130(Pt 1):143-50. PubMed ID: 17105746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vestibular and audiological findings in the Alport syndrome.
    Barozzi S; Soi D; Intieri E; Giani M; Aldè M; Tonon E; Signorini L; Renieri A; Fallerini C; Perin P; Montini G; Ambrosetti U
    Am J Med Genet A; 2020 Oct; 182(10):2345-2358. PubMed ID: 32820599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between hearing loss and vestibular dysfunction in patients with sudden sensorineural hearing loss.
    Niu X; Zhang Y; Zhang Q; Xu X; Han P; Cheng Y; Gao Y; Zhang R; Yang Y; Chen Z; Hu J; Chen Y; Xu M
    Acta Otolaryngol; 2016; 136(3):225-31. PubMed ID: 26587580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nationwide study on enlargement of the vestibular aqueduct in Japan.
    Noguchi Y; Fukuda S; Fukushima K; Gyo K; Hara A; Nakashima T; Ogawa K; Okamoto M; Sato H; Usami SI; Yamasoba T; Yokoyama T; Kitamura K
    Auris Nasus Larynx; 2017 Feb; 44(1):33-39. PubMed ID: 27160786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy.
    Hajioff D; Enever Y; Quiney R; Zuckerman J; Mackermot K; Mehta A
    J Inherit Metab Dis; 2003; 26(8):787-94. PubMed ID: 14739683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Hearing Loss Among a Representative Sample of Canadian Children and Adolescents, 3 to 19 Years of Age.
    Feder KP; Michaud D; McNamee J; Fitzpatrick E; Ramage-Morin P; Beauregard Y
    Ear Hear; 2017; 38(1):7-20. PubMed ID: 27556530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy.
    Suntjens EB; Smid BE; Biegstraaten M; Dreschler WA; Hollak CE; Linthorst GE
    J Inherit Metab Dis; 2015 Mar; 38(2):351-8. PubMed ID: 25395255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY.
    Asquier-Khati A; Mauhin W; Michel G; Gendre A; Durant C; Lavigne C; Maillard H; Lacombe D; Willems M; Lidove O; Masseau A
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1639-1644. PubMed ID: 34825971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inner ear involvement in Fabry disease: Clinical and audiometric evaluation of a large cohort of patients followed in a reference centre.
    Rodrigues J; Azevedo O; Sousa N; Cunha D; Mexedo A; Fonseca R
    Eur J Med Genet; 2018 Jun; 61(6):341-347. PubMed ID: 29307789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vestibular and cochlear manifestations in Fabry's disease].
    Malinvaud D; Germain DP; Benistan K; Bonfils P
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S251-6. PubMed ID: 21211674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Otology manifestations of the Anderson-Fabry disease].
    Pomar Blanco P; San Román Carbajo J; Martín Villares C; Rodríguez Martín F; Paniagua J; Fernández Pello M; Tapia Risueño M
    Acta Otorrinolaringol Esp; 2006 Feb; 57(2):115-7. PubMed ID: 16550865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous triple semicircular canal plugging and cochlear implantation in advanced Meniere's disease].
    Zhang DG; Xu L; Han YC; Lyu YF; Luo JF; Li YW; Wang RJ; Fan ZM; Wang HB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 52(1):25-30. PubMed ID: 28104012
    [No Abstract]   [Full Text] [Related]  

  • 19. Hearing improvement in patients with Fabry disease treated with agalsidase alfa.
    Hajioff D; Goodwin S; Quiney R; Zuckerman J; MacDermot KD; Mehta A
    Acta Paediatr Suppl; 2003 Dec; 92(443):28-30; discussion 27. PubMed ID: 14989462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacculo-collic pathway dysfunction accompanying auditory neuropathy.
    Sheykholeslami K; Schmerber S; Habiby Kermany M; Kaga K
    Acta Otolaryngol; 2005 Jul; 125(7):786-91. PubMed ID: 16012043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.